Patent Yard Sign in
European application, no grantEurope

Process for the preparation of n-methyl-d-phenylalanyl-n- 1- 3- (aminoiminomethyl)amino]propyl]-3,3-difluoro-2-oxohexyl]-l-prolinamide

EP 1012165 A1 · Applicant: Aventis Pharmaceuticals Inc.

EPO PDF

Overview

The published document from the EPO: abstract, claims, description and drawings. Open it full size

Read the whole patent

Listed from its EPO record in Patent Yard's archive of European patents past their term. Its claims, description and drawings are in the EPO PDF and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed February 25, 1997 and never granted as a European patent. Had it been granted, its 20-year term would have ended February 25, 2017.
  • A supplementary protection certificate, which can extend a medicine or crop-protection patent, adds at most five and a half years, so even that would have ended by August 25, 2022.
  • We check European rights only. A US or other national patent in its family could still be in force: check its family on Espacenet or Google Patents.
FiledFebruary 25, 1997
PublishedJune 28, 2000
GrantedNever granted
Term endedFebruary 25, 2017
Application numberEP 97908712
Classification (CPC)C07C277/08 +1 more

Timeline

Timeline From EPO dates

1998200020022004200620082010201220142016Application filedFeb 25, 1997PublishedJune 28, 2000Term endedFeb 25, 2017

Sources & verification